¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reduced viscosity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • kinematic viscosity
    ¿îµ¿ÇÐÀûÁ¡¼ºµµ
  • viscosity
    Á¡µµ, Á¡¼ºµµ
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò, ȯ¿øÇì¸ð±Û·Îºó
  • reduced pelvis
    Ãà¼Ò°ñ¹Ý
  • reduced penetrance
    °¨Åð¹ßÇö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • viscosity
    Á¡¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±âÁ¡¼º
  • kinematic viscosity
    µ¿Á¡µµ, ¿îµ¿ÇÐÀûÁ¡¼º
  • viscosity
    Á¡¼º
  • reduced flavoprotein
    ȯ¿øÇüÇöóºó´Ü¹éÁú
  • reduced heat
    ȯ»ê¿­·®
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò
  • reduced pelvis
    ÇùÂø°ñ¹Ý, Ãà¼Ò°ñ¹Ý
  • reduced penetrance
    °¨Åð¹ßÇö
  • reduced bandwidth technique
    Á֯ļöÆø°¨¼Ò±â¹ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±â Á¡¼º(µµ) (¡­ïÄàõöô).
  • pulmonary viscosity
    ÆóÁ¡¼º(øËïÄàõ).
  • relative viscosity
    »ó´ëÁ¡µµ(ßÓÓßïÄöô).
  • Gullstrands reduced eye
    ±¼½ºÆ®¶õµå»ý·«¾È
  • reduced bandwidth technique
    Á֯ļöÆø °¨¼Ò ±â¹ý
  • reduced body temperature
    Àúü¿Â(¹ý) (î¸ô÷è®Ûö).
  • reduced eye
    »ý·«¾È(ßèå²äÑ).
  • reduced flavoprotein
    ȯ¿øÇüÇö󺸴ܹéÁú.
  • reduced heat
    ȯ»ê¿­·®(üµß©æðåÖ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êª úìßäáÈ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êªúìßäáÈ)
  • reduced illumination
    °¨¾àÁ¶¸í(˧ËâÌ¡ËÎ).
  • reduced iron ³ª ferrum reductum
    ȯ¿øÃ¶(ü½êªôÑ).
  • reduced mass
    ȯ»êÁú·®(üµß©òõåÖ).
  • reduced pelvis
    ÇùÂø°ñ¹Ý(úõó¸ÍéÚï)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apparent viscosity
    °Ñº¸±â Á¡¼º(µµ) (¡­ïÄàõöô).
  • blood viscosity
    Ç÷¾×Á¡ (¼º)µµ.
  • blood viscosity
    Ç÷¾×Á¡(¼º)µµ(úìäûïÃà÷Óø).
  • fluid viscosity
    ¾×üÁ¡µµ
  • kinematic viscosity
    µ¿Á¡µµ(ÔÑïÄöô).
  • melt viscosity
    À¶ÇØÁ¡µµ(¡­ïÄöô).
  • pulmonary viscosity
    ÆóÁ¡¼º(øËïÄàõ).
  • relative viscosity
    »ó´ëÁ¡µµ(ßÓÓßïÄöô).
  • serum viscosity
    Ç÷ûÁ¡µµ, Ç÷ûÁ¡¼º
  • viscosity
    Á¡¼º (ïÄàõ)
  • viscosity
    Á¡¼º(ïÄàõ), Á¡µµ(ïÄöô), Á¡Âø¼º
  • viscosity
    Á¡¼º
  • viscosity
    Á¡¼º(ïÄàõ), Á¡µµ(ïÄöô), Á¡Âø¼º.
  • viscosity formula
    Á¡Á¶µµ°è»ê½Ä.
  • volume viscosity
    üÀûÁ¡¼º·ü(¡­ïÄàõëÒ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced viscosity
    ȯ»ê Á¡µµ(üµß©ïÄÓø)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced mean residue rotation
    ȯ»ê Æò±Õ Àܱâ ȸÀü(üµß©øÁгíÑÐñüÞï®)
  • reduced osmotic pressure
    ȯ»ê »ïÅõ¾Ð(üµß©ß¶÷âäâ)
  • reduced scattered light intensity
    ȯ»ê »ê¶õ±¤ °­µµ(üµß©ß¤Õ¯ÎÃË­Óø)
  • reduced substrate concentration
    ȯ»ê ±âÁú ³óµµ(üµß©Ñ¨òõÒØÓø)
  • coefficient of viscosity
    Á¡µµ°è¼ö(ïÄÓøÌõâ¦)
  • dynamic viscosity
    µ¿Àû Á¡µµ(ÔÑîÜïÇÓø)
  • intrinsic viscosity
    °íÀ¯ Á¡µµ(ͳêóïÄÓø)
  • kinematic viscosity
    µ¿Á¡µµ(ÔÑïÄÓø)
  • limiting viscosity number
    Á¦ÇÑÁ¡µµ¼ö(ð¤ùÚïÄÓøâ¦)
  • relative viscosity
    »ó´ë Á¡µµ(ßÓÓßïÄÓø)
  • specific viscosity
    ºñÁ¡µµ(ÝïïÄÓø)
  • viscosity
    "Á¡¼º(ïÄàõ), Á¡µµ(ïÄÓø)"
  • viscosity-average molecular weight
    Á¡µµ(ïÄÓø)Æò±Õ ºÐÀÚ·®(øÁгÝÂí­Õá)
  • viscosity increment
    Á¡µµ Áõ°¡(ïÄÓøñòÊ¥)
  • viscosity number
    Á¡µµ¼ö(ïÄÓøâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • viscosity
    Á¡¼º, Á¡µµ, Á¡Âø¼º
  • reduced
    °¨ÅðÇÑ
  • reduced bandwidth technique
    ´ëÆø°¨¼Ò±â¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BlV blood viscosity; blood volume
h Greek letter eta; absolute viscosity
LVC low-viscosity cement
MAV mechanical auditory ventricle; minimal alveolar ventilation; minimum apparent viscosity; movement ar...
PV pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PV Plasma viscosity
WBV Whole Blood Viscosity
rcm Reduced and carboxymethylated
RFC Reduced folate carrier
RHAL Reduced haloperidol
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reduced
    °¨ÅðÇÑ
    1. °ñÀýÀÇ Á¤º¹°ú °°ÀÌ ÀûÀýÇÑ À§Ä¡, ¹èÄ¡¿¡ µÇµ¹¸°. 2. ±Ý¼ÓÀÇ ÇüÀ¸·Î µÇµ¹¸°.
  • reduced dental epethelium
    ÅðÃà Ä¡»óÇÇ
  • reduced interoccusal distance
    ÀúÀ§ ±³ÇÕ
  • melt viscosity
    À¶ÇØ Á¡µµ
  • relative viscosity
    »ó´ë Á¡µµ
  • synovial fluid viscosity
    Ȱ¾× Á¡Á¶µµ
  • viscosity
    Á¡¼º, Á¡µµ, Á¡Âø¼º
    1. Àü´Ü·Â¿¡ ´ëÇØ ³»ºÎÀÇ ÀúÇ×À» °áÁ¤ÇÏ´Â À¯Ã¼ÀÇ ¹°¸®Àû ¼ºÁú. 2. ±¸¼º ºÐÀÚ°¡ ¼­·Î ¹Ì²ô·¯Áú ¶§¿Í °°ÀÌ ¸¶Âû¿¡ ÀÇÁ¸ÇÏ´Â ¹°ÁúÀÇ ¹°¸®Àû ¼ºÁú. ÀϹÝÀûÀ¸·Î ºÐÀÚ ÀÀÁý·ÂÀÇ °á°ú·Î¼­ ¹°ÁúÀÌ À¯µ¿°ú ÇüÅ º¯È­¿¡ ÀûÀÀÇÏ´Â °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
reduced enamel epithelium The several layers of the enamel organ remaining on the enamel surface after formation of enamel is completed.
Synonym: reduced enamel epithelium.
(05 Mar 2000)
reduced eye A simplified design of the ocular optical system, represented as having a single refracting surface and a uniform index of refraction; a model based on this concept is used in retinoscopy and ophthalmoscopy.
(05 Mar 2000)
reduced glutathione Glutathione acting as a hydrogen donor.
(05 Mar 2000)
reduced haematin 1. <biochemistry> Compounds of iron complexed in a porphyrin (tetrapyrrole) ring that differ in side chain composition. Haems are the prosthetic groups of cytochromes and are found in most oxygen carrier proteins.
2. <prefix> haem-, eaning relating to blood.
Origin: G. Haima
(21 Jun 2000)
reduced haemoglobin The form of Hb in red blood cells after the oxygen of oxyhemoglobin is released in the tissues.
(05 Mar 2000)
reduced interarch distance An occluding vertical dimension which results in an excessive interocclusal distance when the mandible is in rest position, and in a reduced interridge distance when the teeth are in contact.
(05 Mar 2000)
Listing's reduced eye A representation that simplifies calculations of retinal imagery: radius of anterior refracting surface, 5.1 mm; total length, 20 mm; distance of nodal point to retina, 15 mm.
(05 Mar 2000)
absolute viscosity Force per unit area applied tangentially to a fluid, causing unit rate of displacement of parallel planes separated by a unit distance; units in CGS system: poise.
(05 Mar 2000)
anomalous viscosity The viscous behaviour of nonhomogenous fluids or suspensions, e.g., blood, in which the apparent viscosity increases as flow or shear rate decreases toward zero.
(05 Mar 2000)
apparent viscosity <physiology> This refers to the ratio of shear stress to shear rate in a fluid, this ratio is dependent on the rate of shear.
(09 Oct 1997)
blood viscosity The internal resistance of the blood to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as sickle cell anaemia and polycythemia.
(12 Dec 1998)
magnetic viscosity <physics> A magnetic field in a conducting fluid will damp fluid motions perpendicular to the field lines, similar to ordinary viscosity, even in the absence of sizeable mechanical forces or electric fields.
(09 Oct 1997)
relative viscosity The ratio of the viscosity of a solution or dispersion to the viscosity of the solvent or continuous phase.
(05 Mar 2000)
viscosity <chemistry> A physical property of fluids that determines the internal resistance to shear forces.
(18 Nov 1997)
coefficient of viscosity The value of the force per unit area required to maintain a unit relative velocity between two parallel planes a unit distance apart.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reduced
    ÁÙÀÎ;Ãà¼ÒÇÑ;°¨¼ÒÇÑ;ÇÒÀÎÇÑ;¿µ¶ôÇÑ;¸ô¶ôÇÑ;¼è¾àÇÑ;ȯ¿øÇÑ;±â¾àÀÇ
  • viscosity
    Á¡Áú
  • viscosity
    Á¡Âø¼º;Á¡Áú;Á¡µµ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á